Listen
Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
| Substantial |
The actual benefit of ZEBINIX is substantial. |
Clinical Added Value
| no clinical added value |
In view of the absence of comparative data from other antiepileptic medicinal products and of the results observed in the studies, the transparency Committee considers that ZEBINIX, used in combination with other antiepileptic medicinal products, does not provide an improvement in actual benefit (IAB V) in the management of adult patients with partial-onset epilepsy with or without secondary generalisation. |
English version
Contact Us
Évaluation des médicaments
